Southeast Renal Research Institute
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2008-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.serri.net
Delivery of Inhibitors of Lysyl Oxidase (LysoLox) on Serial Angioplasty and Time to Restenosis
Phase 2
- Conditions
- Arteriovenous Fistula Occlusion
- Interventions
- First Posted Date
- 2017-04-11
- Last Posted Date
- 2017-09-11
- Lead Sponsor
- Southeast Renal Research Institute
- Target Recruit Count
- 30
- Registration Number
- NCT03106948
- Locations
- 🇺🇸
Southeast Renal Research Institute, Chattanooga, Tennessee, United States
Safety and Efficacy of Combination Acthar Gel and Tacrolimus in the Treatment of Steroid Resistant Nephrotic Syndrome
- First Posted Date
- 2017-02-03
- Last Posted Date
- 2021-02-17
- Lead Sponsor
- Southeast Renal Research Institute
- Registration Number
- NCT03042637
- Locations
- 🇺🇸
Nephronet, Chattanooga, Tennessee, United States
Different Doses of Oral Melatonin Supplements in Chronic Kidney Disease (CKD)-Associated Sleep Disorders
Phase 2
- Conditions
- Chronic Kidney DiseaseSleep DisorderEnd Stage Renal Disease
- Interventions
- First Posted Date
- 2013-08-14
- Last Posted Date
- 2017-01-24
- Lead Sponsor
- Southeast Renal Research Institute
- Target Recruit Count
- 53
- Registration Number
- NCT01922999
- Locations
- 🇺🇸
Southeast Renal Research Institute, Chattanooga, Tennessee, United States
Intra-Renal Therapy of Diuretic Unresponsive Acute Kidney Injury
Phase 4
Withdrawn
- Conditions
- Kidney Failures, Acute
- Interventions
- First Posted Date
- 2010-02-23
- Last Posted Date
- 2016-03-28
- Lead Sponsor
- Southeast Renal Research Institute
- Registration Number
- NCT01073189
- Locations
- 🇺🇸
Erlanger Medical Center, Chattanooga, Tennessee, United States
Adrenocorticotropic Hormone (ACTH) Treatment of Nephrotic Range Proteinuria in Diabetic Nephropathy (NRDN)
- First Posted Date
- 2009-12-09
- Last Posted Date
- 2013-05-31
- Lead Sponsor
- Southeast Renal Research Institute
- Target Recruit Count
- 15
- Registration Number
- NCT01028287
- Locations
- 🇺🇸
Southeast Renal Research Institute, Chattanooga, Tennessee, United States
Vitamin D and Carboxy PTH Fragments in Coronary Calcification
Phase 4
Withdrawn
- Conditions
- Parathyroid HormoneEndstage Renal DiseaseCoronary Calcification
- Interventions
- First Posted Date
- 2007-07-17
- Last Posted Date
- 2020-12-23
- Lead Sponsor
- Southeast Renal Research Institute
- Registration Number
- NCT00502268
- Locations
- 🇺🇸
Davita East Charlotte Dialysis Unit, Charlotte, North Carolina, United States
Vasodilators and Anti-Oxidant Therapy in Early ATN
Phase 2
Withdrawn
- Conditions
- Acute Renal Failure
- First Posted Date
- 2006-02-03
- Last Posted Date
- 2016-03-28
- Lead Sponsor
- Southeast Renal Research Institute
- Registration Number
- NCT00286403
- Locations
- 🇺🇸
Mandeep Grewal, Chattanooga, Tennessee, United States
🇺🇸Chawala, M. MD, Washington, District of Columbia, United States
© Copyright 2025. All Rights Reserved by MedPath